08048035996
Leading exporter of Genuine MYCEPT 500MG Tablets from India to Singapore - Tampines | Phoenix Exim

1. General Information

MYCEPT 500 MG Tablets are an immunosuppressive medicine containing mycophenolate mofetil 500 mg as the active ingredient. It is primarily used as part of an immunosuppressive treatment regimen following organ transplantation to reduce the risk of organ rejection.

The medicine works by reducing certain immune-system activities that can cause the body to recognize a transplanted organ as foreign and attack it. Mycept 500 is generally used in combination with other immunosuppressive medicines according to the transplant specialist's treatment plan.

Brand: MYCEPT 500 MG
Active ingredient: Mycophenolate mofetil 500 mg
Dosage form: Film-coated tablet
Therapeutic class: Immunosuppressant
Prescription status: Prescription medicine
Typical pack: 10 tablets per strip; packaging can vary by market and manufacturer batch.


2. Product Information

MYCEPT 500 MG contains mycophenolate mofetil, which is converted in the body to mycophenolic acid, the active immunosuppressive compound.

The product is manufactured in India by pharmaceutical manufacturers associated with the MYCEPT brand; current Indian listings identify Panacea Biotec for MYCEPT 500 MG, although marketer/manufacturer details can vary between listings and markets. Therefore, buyers should verify the exact manufacturer, batch, packaging and registration documents before procurement.

Composition: Mycophenolate mofetil 500 mg
Form: Oral tablet
Storage: Store according to the product label; some Indian listings specify storage below 30°C.


3. Uses of MYCEPT 500 MG

MYCEPT 500 MG is primarily used:

  • To help prevent rejection of a transplanted kidney

  • To help prevent rejection of a transplanted heart

  • To help prevent rejection of a transplanted liver

  • As part of a combination immunosuppressive regimen prescribed after transplantation

The medicine is generally used together with other medicines selected by the transplant team.


4. Benefits of MYCEPT 500 MG

The principal benefit of MYCEPT 500 MG is its ability to suppress excessive immune activity following organ transplantation.

Potential therapeutic benefits include:

  • Helps reduce the risk of transplanted-organ rejection.

  • Helps the body tolerate the transplanted organ.

  • Supports long-term transplant management when used as prescribed.

  • Can be incorporated into combination immunosuppressive therapy.

It is important to understand that MYCEPT does not independently guarantee prevention of rejection; treatment must be individualized and monitored by a transplant specialist.


5. Side Effects of MYCEPT 500 MG

Because MYCEPT suppresses the immune system, it can increase susceptibility to infections and may affect blood-cell counts.

Possible adverse effects include:

  • Diarrhea

  • Nausea or vomiting

  • Abdominal or digestive discomfort

  • Increased susceptibility to infections

  • Reduced white blood-cell counts

  • Headache or fatigue

  • Skin rash or other skin reactions

  • Changes in blood-cell counts

Some adverse effects can be serious. Patients should contact their doctor promptly if they develop signs of infection, unusual bleeding or bruising, persistent fever, or other concerning symptoms.


6. Common Side Effects

Commonly reported side effects can include:

  1. Diarrhea

  2. Vomiting

  3. Nausea

  4. Infections

  5. Reduced white blood-cell counts

  6. Headache

  7. Fatigue

  8. Stomach or abdominal discomfort

Not every patient experiences these effects, and the severity can vary. Persistent or severe symptoms should be discussed with the treating physician.


7. How to Use MYCEPT 500 MG

Take MYCEPT 500 MG exactly as prescribed by your doctor. The dose and frequency depend on the type of transplant and the patient's individual treatment plan.

General administration guidance includes:

  • Swallow the tablet whole with water.

  • Do not crush, chew, or break the tablet unless specifically instructed by a healthcare professional.

  • Take it consistently at the prescribed times every day.

  • Do not stop treatment suddenly without medical advice.

  • Follow the transplant team's instructions regarding food and timing.

Some product information recommends taking the tablet on an empty stomach, while patients should follow the specific instructions supplied with their prescription and product label.


8. How MYCEPT 500 MG Works

MYCEPT contains mycophenolate mofetil, which is converted into mycophenolic acid in the body.

Mycophenolic acid inhibits an enzyme involved in purine synthesis, an important process required for the growth and multiplication of certain immune cells, particularly lymphocytes.

By reducing the proliferation of these immune cells, the medicine decreases the immune response against the transplanted organ and thereby helps reduce the likelihood of organ rejection.


9. Safety Advice for MYCEPT 500 MG

Prescription only: MYCEPT 500 MG should be taken only under appropriate medical supervision.

Pregnancy: Mycophenolate can cause serious harm to an unborn baby and is associated with an increased risk of pregnancy loss and birth defects. Women who could become pregnant require specific contraceptive and pregnancy-testing guidance from their healthcare professional.

Infections: Because the medicine suppresses immunity, patients may be more susceptible to infections. Seek medical advice promptly for fever, sore throat, persistent cough, or other signs of infection.

Blood monitoring: Doctors may perform regular blood tests to monitor blood-cell counts and other parameters during treatment.

Sun exposure: Immunosuppression can increase the risk of certain skin cancers. Patients should minimize excessive sun exposure and use suitable protective measures.

Vaccinations: Discuss vaccinations with the treating physician because some vaccines may not be appropriate during significant immunosuppression.

Drug interactions: Inform the doctor about all prescription medicines, OTC medicines, supplements, and herbal products being taken.

Do not discontinue suddenly: Stopping immunosuppressive treatment without medical advice can increase the risk of transplant rejection.


10. Frequently Asked Questions (FAQs)

Q1. What is MYCEPT 500 MG used for?

MYCEPT 500 MG is primarily used with other immunosuppressive medicines to help prevent rejection of transplanted organs such as the kidney, heart, or liver.

Q2. What is the active ingredient in MYCEPT 500 MG?

The active ingredient is mycophenolate mofetil 500 mg.

Q3. Is MYCEPT 500 MG a prescription medicine?

Yes. MYCEPT 500 MG is a prescription immunosuppressant and should be used under medical supervision.

Q4. Can I stop taking MYCEPT when I feel better?

No. Transplant patients should not stop or change their immunosuppressive treatment without consulting their transplant physician.

Q5. Can MYCEPT 500 MG increase the risk of infection?

Yes. Since it suppresses immune-system activity, it can increase susceptibility to infections.

Q6. Does MYCEPT 500 MG require regular monitoring?

Yes. Your physician may recommend regular blood tests and clinical monitoring during treatment.

Q7. Can MYCEPT be used during pregnancy?

Mycophenolate can cause serious fetal harm and pregnancy loss. Patients who are pregnant, planning pregnancy, or capable of becoming pregnant should discuss this medicine with their doctor before treatment.

Q8. What should I do if I miss a dose?

Follow the instructions provided by your transplant team. Do not take a double dose unless your doctor specifically tells you to do so.

Q9. Can MYCEPT 500 MG be substituted with another medicine?

Potential substitutes containing mycophenolate mofetil exist, but substitution should be made only with approval from the treating physician because immunosuppressive therapy requires careful management.


11. Substitute for MYCEPT 500 MG

Possible mycophenolate mofetil 500 mg alternatives listed in Indian pharmaceutical references include:

  • Mycofit 500 Tablet

  • Mofilet 500 Tablet

  • Renodapt 500 Tablet

  • Mofetyl 500 Tablet

  • Cellmune 500 mg Tablet

These products may contain the same active ingredient, but brand, manufacturer, formulation, availability, registration status, and excipients can differ. A doctor or pharmacist should confirm whether a substitution is appropriate, particularly in transplant patients.


12. Keywords

Primary Keywords:

MYCEPT 500 MG Tablets, Mycept 500mg Tablet, Mycept 500 mg, Mycophenolate Mofetil 500mg, Mycophenolate Mofetil Tablets, Mycophenolate Mofetil 500mg Tablets, Mycept Tablets, Immunosuppressant Tablets, Organ Transplant Medicine, Anti Rejection Medicine, Transplant Immunosuppressant, Kidney Transplant Medicine, Heart Transplant Medicine, Liver Transplant Medicine.

Long-Tail B2B / Export Keywords:

Mycept 500mg Tablets supplier India, Mycept 500mg Tablets exporter India, Mycept 500mg Tablets wholesale supplier, Mycept 500mg Tablets pharmaceutical exporter, Mycophenolate Mofetil 500mg supplier India, Mycophenolate Mofetil 500mg exporter from India, Mycept 500mg wholesale pharmaceutical supplier, Mycept 500mg tablets international supplier, Mycept 500mg tablets for pharmaceutical procurement, Mycept 500mg tablets for hospital procurement, Mycept 500mg tablets bulk supply, Mycophenolate Mofetil 500mg bulk supplier India, transplant medicines exporter India, immunosuppressant medicine exporter India, pharmaceutical medicine exporter from Nagpur India.

Destination-Focused Keywords:

Mycept 500mg Tablets exporter to USA, Mycept 500mg Tablets supplier to UK, Mycept 500mg Tablets exporter to Australia, Mycept 500mg Tablets supplier to Singapore, Mycept 500mg Tablets exporter to Canada, Mycept 500mg Tablets supplier to South Korea, Mycept 500mg Tablets exporter to UAE, Mycophenolate Mofetil 500mg exporter from Nagpur India, transplant medicine supplier India to international markets.


Aug 19th, 2026 3:25 PM

Keywords